Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Meditation—an effective new therapy to reduce eye pressure in primary open-angle glaucoma

Meditation—an effective new therapy to reduce eye pressure in primary open-angle glaucoma

Meditation—an effective new therapy to reduce eye pressure in primary open-angle glaucoma
Meditators and non-meditators had similar parameters before start of the study. After 3 weeks of meditation, there was significant lowering of intraocular pressure (IOP), cortisol and levels of oxidative stress, while there was an increase in brain-derived neurotrophic factors and beta endorphins with improvement in quality of life measures (QOL) in the meditators, while there was no change in the non-meditators. Credit: Otto-v.-Guericke Universität Magdeburg

A new era in the management of glaucoma is ushered in by a landmark study published in the Journal of Glaucoma, official journal of the World Glaucoma Association. Patients with primary open angle glaucoma (POAG) showed significant improvements of both ocular and general health after participating in a program of mindfulness meditation focused on breathing compared to the control group that did not partake.

“We know that chronic stress can lead to elevation of blood pressure (systemic hypertension), but seldom think about its known effect on the eye by provoking high intraocular pressure (IOP). This is the first study showing that a relaxation program with meditation can lower IOP in glaucoma patients and improve their quality of life by lowering stress hormones like cortisol. Mindfulness meditation is easy to do, even by patients who are elderly and bedridden,” said the study’s lead investigator Tanuj Dada, MD, from the Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Co-investigator Bernhard Sabel, Ph.D. from the Institute of Medical Psychology, Otto-.v.-Guericke University of Magdeburg, Germany, added, “The study suggests that mental stress may be one of the main causal factors for glaucoma, and using this ancient meditation technique to reduce stress is a powerful tool to treat the patient as a whole and not just the eye, a holistic approach to manage the disease and also improve overall patient well-being.”

The scientists randomly divided 90 POAG patients (all of whom were being treated with eye drops before and during the study) into two groups. One group underwent a three-week program of meditation and breathing exercises with a trained yoga instructor for 60 minutes every morning while continuing taking their eye drops. The second group also continued taking the eye drops but did not meditate. At the end of three weeks, 75% of the patients who practiced meditation demonstrated a significant 25% drop in eye pressure, which was not observed in the control group. Additionally, meditation positively influenced other indicators, such as reduced cortisol levels (stress hormone), increases in beta-endorphins and brain-derived neurotrophic factors and reduced oxidative stress and pro-inflammatory markers (interleukins).

Glaucoma is the leading cause of blindness globally, affecting nearly 70 million people. Lowering of IOP is the only proven therapy, which is currently achieved with eye drops, laser therapy or surgery. These therapies are costly and have ocular and systemic side effects that can adversely affect the health-related quality of life of glaucoma patients. Patients’ outcomes improve as IOP is reduced, which helps to prevent further damage to the optic nerve. By employing a meditation approach, there is a reduced need for medications, which helps reduce side effects and also costs to the patient and the healthcare system. In addition, meditation reduces stress hormones, which improves patients’ quality of life. It thus helps patients cope much more successfully with the psychological burden caused by this blinding disorder.

“Our findings open an exciting avenue of harnessing the power of the brain to cure ailments of the human body. A majority of human diseases have an underlying psychological component, and it is the psychology of the patient that meditation targets. Reducing stress hormone levels with evidence-based methods can impact many organs in the body, including the eyes. More research is now needed to explore the exciting prospect of whether meditation can also serve to reduce or stop the progression of vision loss or even achieve vision restoration,” explained study co-author Muneeb Faiq, Ph.D., All India Institute of Medical Sciences, New Delhi, India.

Although yoga and meditation, key elements for holistic health, have been practiced for more than 5,000-years in ancient India, they are not well known to modern doctors and currently not used in medical practice. Most people identify yoga with physical postures and exercises, although the most benefit comes from breathing exercises and meditation that reduce stress hormone release by relaxation and thus harmonize the “mind-body” relationship.


How meditation affects the brain to help you stress less


More information:
Tanuj Dada et al. Mindfulness Meditation Reduces Intraocular Pressure, Lowers Stress Biomarkers and Modulates Gene Expression in Glaucoma, Journal of Glaucoma (2018). DOI: 10.1097/IJG.0000000000001088


Provided by
Otto-v.-Guericke Universität Magdeburg

Citation:
Meditation—an effective new therapy to reduce eye pressure in primary open-angle glaucoma (2018, November 6)
retrieved 13 January 2019
from https://medicalxpress.com/news/2018-11-meditationan-effective-therapy-eye-pressure.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Tagged with:

About author

Related Articles